Company
Headquarters: New York, NY, United States
CEO: Mr. Nicholas Keane Vita
$192.6 Million
USD as of July 1, 2023
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Columbia Care Inc. cultivates, manufactures, and provides cannabis-based health and wellness solutions, and derivative products. It offers flowers, edibles, oils, and tablets under the Cannabist, Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label Cannabidiol brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of January 3, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
Columbia Care, Inc. has the following listings and related stock indices.
Stock: OTC: CCHWF
Stock: CSE: CCHW
Stock: FSX: 3LP